Clinical Practice Protocol for Management of Women of Childbearing-Age with Epilepsy

Bibliographic Details
Main Author: Ferro, Margarida
Publication Date: 2023
Other Authors: Serôdio, Miguel, Beja, Mariana, Menezes Cordeiro, Inês, Parra, Joana, Sá, Francisca
Format: Article
Language: por
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://doi.org/10.46531/sinapse/GU/230019/2023
Summary: Women of childbearing-age with epilepsy presents with challenges in prevention, planning and orientation of gestation and post-partum. Gestation in women with epilepsy represents 0.3% to 0.5% of all pregnancies, and one third of women with epilepsy is in childbearing-age. Epilepsy may be associated with serious complications in pregnant women, with a higher risk of congenital malformations, intrauterine growth restriction and neurocognitive development disorders in children, due to adverse effects of antiseizure drugs (ASD). Women should be informed that the risk of fetal congenital malformations depends on the type, number, and dosage of ASD. The choice of drugs associated with a lower incidence of congenital malformations, as well as monitoring and adjusting its dosage are essential for an adequate seizure control. Choosing the treatment for women of childbearing-age should be based on an early and shared decision between patient and doctor, and when appropriate, shared with the patient’s legal representative as well. Discussions should include careful evaluation of the risk-benefit relationship of reasonable drugs for the type of seizures/epilepsy. Women of childbearing-age and pregnant women with epilepsy should also be informed of the low risk of seizures and complications during labor. Vaginal delivery should be considered, as epilepsy is not a formal indication for cesarian delivery. A careful follow-up in post-partum is also fundamental, in which is important to check dosages of ASD, reintroduce contraceptive methods and reassure that care has been taken to minimize the risk of maternal and newborn lesions due to seizures. Follow-up should be multidisciplinary, including the attending neurologist, obstetrician, and general physician. We present a clinical practice protocol that aims to guide multidisciplinary teams managing women of childbearing-age with epilepsy, regarding contraception, fertility, pregnancy and post-partum period.
id RCAP_3dce44c10182a40b30dc6f43c601b9a8
oai_identifier_str oai:sinapse.pt:article/25
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Clinical Practice Protocol for Management of Women of Childbearing-Age with EpilepsyProtocolo de Seguimento de Mulher em Idade Fértil e Grávida com EpilepsiaAnticonvulsants/therapeutic useEpilepsy/drug therapyFemaleLactationPregnancyAnticonvulsivantes/uso terapêuticoEpilepsia/tratamento farmacológicoGravidezLactaçãoMulherWomen of childbearing-age with epilepsy presents with challenges in prevention, planning and orientation of gestation and post-partum. Gestation in women with epilepsy represents 0.3% to 0.5% of all pregnancies, and one third of women with epilepsy is in childbearing-age. Epilepsy may be associated with serious complications in pregnant women, with a higher risk of congenital malformations, intrauterine growth restriction and neurocognitive development disorders in children, due to adverse effects of antiseizure drugs (ASD). Women should be informed that the risk of fetal congenital malformations depends on the type, number, and dosage of ASD. The choice of drugs associated with a lower incidence of congenital malformations, as well as monitoring and adjusting its dosage are essential for an adequate seizure control. Choosing the treatment for women of childbearing-age should be based on an early and shared decision between patient and doctor, and when appropriate, shared with the patient’s legal representative as well. Discussions should include careful evaluation of the risk-benefit relationship of reasonable drugs for the type of seizures/epilepsy. Women of childbearing-age and pregnant women with epilepsy should also be informed of the low risk of seizures and complications during labor. Vaginal delivery should be considered, as epilepsy is not a formal indication for cesarian delivery. A careful follow-up in post-partum is also fundamental, in which is important to check dosages of ASD, reintroduce contraceptive methods and reassure that care has been taken to minimize the risk of maternal and newborn lesions due to seizures. Follow-up should be multidisciplinary, including the attending neurologist, obstetrician, and general physician. We present a clinical practice protocol that aims to guide multidisciplinary teams managing women of childbearing-age with epilepsy, regarding contraception, fertility, pregnancy and post-partum period.A mulher com epilepsia em idade fértil apresenta desafios na prevenção, planeamento e orientação da gravidez e pós-parto. A gravidez em mulheres com epilepsia representa 0,3% a 0,5% de todas as gravidezes e um terço das mulheres com epilepsia encontra-se em idade fértil. A epilepsia pode estar associada a riscos particularmente graves nas mulheres grávidas, com aumento do risco de morte materna, efeitos adversos no feto por crises não controladas, risco de malformações congénitas, restrição de crescimento intrauterino e perturbações do desenvolvimento neurocognitivo da criança, associados ao efeito dos fármacos anti-crises epiléticas (FACE). A mulher deve ser informada de que o risco de teratogenicidade é dependente do tipo, número e dose dos FACE. O conhecimento e preferência de fármacos associados a menor incidência de malformações congénitas, bem como a monitorização e ajuste de doses destes durante a gravidez são essenciais para um bom controlo de crises. A escolha do tratamento para as mulheres em idade fértil deve basear-se numa decisão atempada e compartilhada entre médico e doente e, quando apropriado, também compartilhada com o seu representante legal. Nesse contexto, deve ser realizada uma avaliação cuidadosa do risco-benefício das opções terapêuticas disponíveis para o tipo de crises epiléticas ou de epilepsia da doente. A mulher em idade fértil e/ou grávida com epilepsia deve ser informada da baixa taxa de crises e complicações durante o trabalho de parto. A via de parto tem em conta critérios obstétricos, não sendo a epilepsia indicação formal para parto por cesariana. É igualmente fundamental um acompanhamento cuidado no período pós-parto, sendo de maior importância a verificação da necessidade de ajuste terapêutico, aconselhamento na reintrodução de métodos contracetivos tendo em conta possíveis interações medicamentosas, e orientação de cuidados a ter com o recém-nascido de forma a prevenir lesões decorrentes de eventuais crises epiléticas. O acompanhamento deve ser feito de forma multidisciplinar pelo médico neurologista, obstetra e médico de família assistente. Apresentamos um protocolo de atuação clínica que tem como objetivo a orientação de equipas multidisciplinares nas diferentes etapas da mulher em idade fértil com epilepsia, relativamente à contraceção, fertilidade, gravidez e período pós-parto.Portuguese Society of Neurology2023-07-18info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.46531/sinapse/GU/230019/2023https://doi.org/10.46531/sinapse/GU/230019/2023Sinapse; Vol. 23 No. 2 (2023): April - June; 111-124Sinapse; Vol. 23 N.º 2 (2023): Abril - Junho; 111-1242184-42401645-281Xreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPporhttps://sinapse.pt/index.php/journal/article/view/25https://sinapse.pt/index.php/journal/article/view/25/24Ferro, MargaridaSerôdio, MiguelBeja, MarianaMenezes Cordeiro, InêsParra, JoanaSá, Franciscainfo:eu-repo/semantics/openAccess2024-04-30T10:08:46Zoai:sinapse.pt:article/25Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T13:33:55.265905Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Clinical Practice Protocol for Management of Women of Childbearing-Age with Epilepsy
Protocolo de Seguimento de Mulher em Idade Fértil e Grávida com Epilepsia
title Clinical Practice Protocol for Management of Women of Childbearing-Age with Epilepsy
spellingShingle Clinical Practice Protocol for Management of Women of Childbearing-Age with Epilepsy
Ferro, Margarida
Anticonvulsants/therapeutic use
Epilepsy/drug therapy
Female
Lactation
Pregnancy
Anticonvulsivantes/uso terapêutico
Epilepsia/tratamento farmacológico
Gravidez
Lactação
Mulher
title_short Clinical Practice Protocol for Management of Women of Childbearing-Age with Epilepsy
title_full Clinical Practice Protocol for Management of Women of Childbearing-Age with Epilepsy
title_fullStr Clinical Practice Protocol for Management of Women of Childbearing-Age with Epilepsy
title_full_unstemmed Clinical Practice Protocol for Management of Women of Childbearing-Age with Epilepsy
title_sort Clinical Practice Protocol for Management of Women of Childbearing-Age with Epilepsy
author Ferro, Margarida
author_facet Ferro, Margarida
Serôdio, Miguel
Beja, Mariana
Menezes Cordeiro, Inês
Parra, Joana
Sá, Francisca
author_role author
author2 Serôdio, Miguel
Beja, Mariana
Menezes Cordeiro, Inês
Parra, Joana
Sá, Francisca
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Ferro, Margarida
Serôdio, Miguel
Beja, Mariana
Menezes Cordeiro, Inês
Parra, Joana
Sá, Francisca
dc.subject.por.fl_str_mv Anticonvulsants/therapeutic use
Epilepsy/drug therapy
Female
Lactation
Pregnancy
Anticonvulsivantes/uso terapêutico
Epilepsia/tratamento farmacológico
Gravidez
Lactação
Mulher
topic Anticonvulsants/therapeutic use
Epilepsy/drug therapy
Female
Lactation
Pregnancy
Anticonvulsivantes/uso terapêutico
Epilepsia/tratamento farmacológico
Gravidez
Lactação
Mulher
description Women of childbearing-age with epilepsy presents with challenges in prevention, planning and orientation of gestation and post-partum. Gestation in women with epilepsy represents 0.3% to 0.5% of all pregnancies, and one third of women with epilepsy is in childbearing-age. Epilepsy may be associated with serious complications in pregnant women, with a higher risk of congenital malformations, intrauterine growth restriction and neurocognitive development disorders in children, due to adverse effects of antiseizure drugs (ASD). Women should be informed that the risk of fetal congenital malformations depends on the type, number, and dosage of ASD. The choice of drugs associated with a lower incidence of congenital malformations, as well as monitoring and adjusting its dosage are essential for an adequate seizure control. Choosing the treatment for women of childbearing-age should be based on an early and shared decision between patient and doctor, and when appropriate, shared with the patient’s legal representative as well. Discussions should include careful evaluation of the risk-benefit relationship of reasonable drugs for the type of seizures/epilepsy. Women of childbearing-age and pregnant women with epilepsy should also be informed of the low risk of seizures and complications during labor. Vaginal delivery should be considered, as epilepsy is not a formal indication for cesarian delivery. A careful follow-up in post-partum is also fundamental, in which is important to check dosages of ASD, reintroduce contraceptive methods and reassure that care has been taken to minimize the risk of maternal and newborn lesions due to seizures. Follow-up should be multidisciplinary, including the attending neurologist, obstetrician, and general physician. We present a clinical practice protocol that aims to guide multidisciplinary teams managing women of childbearing-age with epilepsy, regarding contraception, fertility, pregnancy and post-partum period.
publishDate 2023
dc.date.none.fl_str_mv 2023-07-18
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.46531/sinapse/GU/230019/2023
https://doi.org/10.46531/sinapse/GU/230019/2023
url https://doi.org/10.46531/sinapse/GU/230019/2023
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://sinapse.pt/index.php/journal/article/view/25
https://sinapse.pt/index.php/journal/article/view/25/24
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Portuguese Society of Neurology
publisher.none.fl_str_mv Portuguese Society of Neurology
dc.source.none.fl_str_mv Sinapse; Vol. 23 No. 2 (2023): April - June; 111-124
Sinapse; Vol. 23 N.º 2 (2023): Abril - Junho; 111-124
2184-4240
1645-281X
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833593874297126912